Process induced disorder in crystalline materials: Differentiating defective crystals from the amorphous form of griseofulvin

Journal of Pharmaceutical Sciences

Volumn 97, Issue 8, 2008, Pages 3207-3221

  Feng, Tao ^a   Pinal, Rodolfo ^a   Carvajal, M Teresa ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Amorphous; Crystal defects; Crystallinity; Disorder; DSC; Griseofulvin; Milling

Indexed keywords

GRISEOFULVIN;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STRUCTURE; GLASS TRANSITION TEMPERATURE; HEATING; PHYSICAL CHEMISTRY; RAMAN SPECTROMETRY; THERMAL ANALYSIS; X RAY CRYSTALLOGRAPHY; X RAY POWDER DIFFRACTION;

EID: 52449117081     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21219     Document Type: Article

References (36)

1. York P. 1983. Solid-state properties of powders in the formulation and processing of solid dosage forms. Int J Pharm 14:1-28.
2. Huttenrauch R, Fricke S, Zielke P. 1985. Mechanical activation of pharmaceutical systems. Pharm Res 6:302-306.
3. Adam G, Gibbs JH. 1965. On the temperature dependence of cooperative relaxation properties in glass-forming liquids. J Chem Phys 43:139-146.
4. Angell CA. 1995. Formation of glasses from liquids and biopolymers. Science 267:1924-1935.
5. 4-y. Phys Rev B 36:4007-4010.
6. Dai HJ, Wong EW, Lieber CM. 1996. Probing electrical transport in nanomaterials: Conductivity of individual carbon nanotubes. Science 272:523-526.
7. Miracle DB. 1993. Overview No. 104 - The physical and mechanical properties of NiAl. Acta Metall Mater 41:649-684.
8. Jastrzebski ZD. 1987. Defects and imperfections in solids. In: Jastrzebski ZD, editor. The nature and properties of engineering materials. 3rd edition. New York: John Wiley & Sons, Inc.
9. Gallagher HG, Vrcelj RM, Sherwood JN. 2003. The crystal growth and perfection of 2,4,6-trinitrotoluene. J Cryst Growth 250:486-498.
10. Prasad KVR, Ristic RI, Sheen DB, Sherwood JN. 2001. Crystallization of paracetamol from solution in the presence and absence of impurity. Int J Pharm 215:29-44.
11. Brahadeeswaran S, Venkataramanan V, Sherwood JN, Bhat HL. 1998. Crystal growth and characterization of semiorganic nonlinear optical material: Sodium p-nitrophenolate dihydrate. J Mat Chem 8:613-618.
12. Venkataramanan V, Maheswaran S, Sherwood JN, Bhat HL. 1997. Crystal growth and physical characterization of the semiorganic bis(thiourea) cadmium chloride. J Cryst Growth 179:605-610.
13. Bhat HL, Klapper H, Roberts KJ. 1995. An X-ray topographic study of the paraelectric-to-ferroelectric phase transformation in nearly perfect single crystals of ammonium sulfate. J Appl Crystallogr 28:168-188.
14. Elban WL, Armstrong RW, Yoo KC, Rosemeier RG, Yee RY. 1989. X-ray reflection topographic study of growth defect and microindentation strain fields in an rdx explosive crystal. J Mater Sci 24:1273-1280.
15. Parrott EL. 1990. Comminution. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. 2nd edition. New York: Marcel Decker, Inc. pp 101-121.
16. Otsuka M, Kaneniwa N. 1983. Effect of grinding on the degree of crystallinity of cephalexin powder. Chem Pharm Bull 31:4489-4495.
17. Crowley KJ, Zografi G. 2002. Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability. J Pharm Sci 91: 492-507.
18. Otsuka M, Matsumoto T, Kaneniwa N. 1986. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem Pharm Bull 34:1784-1793.
19. Otsuka M, Kaneniwa N, Matsumoto T. 1986. Relation between the transformation of indomethacin polymorphs during grinding and environmental temperature, and stability of noncrystalline solids obtained by grinding. J Parmacobio Dyn 9:S-2.
20. Otsuka M, Kaneniwa N. 1986. Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding. J Pharm Sci 75:506-511.
21. Kaneniwa N, Otsuka M. 1985. Effect of grinding on the transformations of polymorphs of chloramphenicol palmitate. Chem Pharm Bull 33:1660-1668.
22. Matsumoto T, Ichikawa J, Kaneniwa N, Otsuka M. 1988. Effect of environmental temperature on the polymorphic transformation of phenylbutazone during grinding. Chem Pharm Bull 36:1074-1085.
23. Otsuka M, Ofusa T, Matsuda Y. 1999. Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding. Colloids Surf B 13:263-273.
24. Qiu ZH, Stowell JG, Morris KR, Byrn SR, Pinal R. 2005. Kinetic study of the Maillard reaction between metoclopramide hydrochloride and lactose. Int J Pharm 303:20-30.
25. Qiu ZH, Stowell JG, Cao WJ, Morris KR, Byrn SR, Carvajal MT. 2005. Effect of milling and compression on the solid-state Maillard reaction. J Pharm Sci 94:2568-2580.
26. Sheth AR, Lubach JW, Munson EJ, Muller FX, Grant DJW. 2005. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. J Am Chem Soc 127:6641-6651.
27. Byrn SR, Pfeiffer RR, Stowell JG. 1999. Particle-size reduction. In: Byrn SR, Pfeiffer RR, Stowell JG, editors. Solid state chemistry of drugs. 2nd edition. West Lafayette: SSCI, Inc.
28. Bates S, Zografi G, Engers D, Morris K, Crowley K, Newman A. 2006. Analysis of amorphous and nano-crystalline solids from their X-ray diffraction patterns. Pharm Res 23:2333-2349.
29. Fecht HJ. 1992. Defect-induced melting and solid-state amorphization. Nature 356:133-135.
30. 2 during high energy milling. J Mater Sci 35:6015-6026.
31. Elamin AA, Ahlneck C, Alderborn G, Nystrom C. 1994. Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure. Int J Pharm 111:159-170.
32. Townley ER. 1979. Griseofulvin. In: Florey K, editor. Analytical profiles of drug substances. New York: Academic Press, Inc. pp 228-229.
33. Spitzig WA, Pelton AR, Laabs FC. 1987. Characterization of the strength and microstructure of heavily cold-worked Cu-Nb composites. Acta Metall 35:2427-2442.
34. Rios PR, Siciliano F, Jr., Sandim HRZ, Plaut RL, Padilha AF. 2005. Nucleation and growth during recrystallization. Mater Res 8:225-238.
35. Kolerov OK. 1973. Characteristics of primary recrystallization and its role in the sintering of metal powders. Powder Metall Met Ceram 12: 192.
36. Suryanarayanan R, Mitchell AG. 1985. Evaluation of two concepts of crystallinity using calcium gluceptate as a model-compound. Int J Pharm 24: 1-117.